Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
Shino D MagakiRadha SatyadevZesheng ChenKathryn S YungHarry V VintersMarsha C KinneyJonathan W SaidPublished in: Brain tumor pathology (2021)
Anaplastic large cell lymphomas (ALCL) are mature T-cell neoplasms, approximately half of which harbor rearrangements of the ALK gene that confer a good prognosis. Recent studies have demonstrated that a significant proportion of ALK-negative ALCLs demonstrate rearrangements of the IRF4/DUSP22 locus that also are typically associated with a favorable prognosis. ALCL with primary involvement of the central nervous system (CNS) is extremely rare. We report what may be the first case of ALK-negative ALCL with IRF4/DUSP22 rearrangement involving the brain in a 55-year-old man. Magnetic resonance imaging demonstrated signal abnormalities in the periventricular region, corpus callosum and cingulate gyrus. Biopsy revealed a diffuse parenchymal and angiocentric infiltrate of CD30-positive cells that showed IRF4/DUSP22 rearrangement by fluorescence in situ hybridization. We also review the clinical and pathologic features of primary CNS ALK-negative ALCLs in the literature and highlight the need for awareness of this entity to optimize appropriate management.
Keyphrases
- advanced non small cell lung cancer
- single cell
- dendritic cells
- magnetic resonance imaging
- induced apoptosis
- cell therapy
- blood brain barrier
- computed tomography
- systematic review
- cerebrospinal fluid
- squamous cell carcinoma
- functional connectivity
- transcription factor
- gene expression
- epidermal growth factor receptor
- neoadjuvant chemotherapy
- resting state
- genome wide
- ultrasound guided
- case control
- high grade
- cerebral ischemia
- fine needle aspiration